Valuation: Kwality Pharmaceuticals Limited

Market Cap 3.82TCr 39Cr 35Cr 33Cr 30Cr 56Cr 57Cr 395.66Cr 154.58Cr 1.94TCr 148.28Cr 145.07Cr 6.25TCr P/E 2025
22.6x
P/E 2026 20.1x
Enterprise Value 3.95TCr 41Cr 36Cr 34Cr 31Cr 58Cr 59Cr 408.82Cr 159.72Cr 2.01TCr 153.21Cr 149.9Cr 6.45TCr EV / Sales 2025
2.7x
EV / Sales 2026 2.95x
Free-Float
22.51%
Yield 2025 *
-
Yield 2026 -
21/09 Kwality Pharmaceuticals Limited(BSE:539997) added to S&P Global BMI Index CI
02/09 Kwality Pharmaceuticals Limited Appoints Swanith Kapoor, as the Non-Executive Independent Director, Effective 02 June, 2026 CI
10/08 Kwality Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
02/06 Kwality Pharmaceuticals Limited Announces Resignation of Kartik Kapur as Independent Director, Effective June 02, 2026 CI
19/05 Kwality Pharmaceuticals' Consolidated Profit Rises in Fiscal Q4; Shares Jump 9% MT
19/05 Kwality Pharmaceuticals Limited Provides Earnings Guidance for the Fiscal Year 2027 CI
19/05 Kwality Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
11/03 Chatha Foods Limited Announces Change in Designation of Mrs. Rachna Singh Chaudhary as Chief Human Resource Officer, Effective March 11, 2026 CI
10/03 Kwality Pharmaceuticals completes phase 1 BE studies for three molecules RE
12/02 Kwality Pharmaceuticals' Consolidated Profit Jumps in Fiscal Q3; Shares Surge 16% MT
12/02 Kwality Pharmaceuticals Ltd Dec-quarter consol net profit 160.1 million rupees RE
12/02 Kwality Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
02/02 Kwality Pharmaceuticals Limited Announces Completion of Term of Pankaj Takkar and Ravi Shanker as Independent Directors and from Committees Membership and Chairmanship, Effective January 31, 2026 CI
1 day-3.24%
1 week-2.02%
Current month-2.02%
1 month+4.43%
3 months+39.83%
6 months+137.73%
Current year+221.46%
1 week 3,473.95
Extreme 3473.95
3,780.2
1 month 3,132.8
Extreme 3132.8
3,866.55
Current year 1,020
Extreme 1020
3,866.55
1 year 828.8
Extreme 828.8
3,866.55
3 years 320
Extreme 320
3,866.55
5 years 248
Extreme 248
3,866.55
10 years 21.3
Extreme 21.3
3,866.55
Manager TitleAgeSince
Chief Executive Officer 72 04/05/1983
Director of Finance/CFO 32 22/10/2015
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 72 04/05/1983
Director/Board Member 58 01/08/1995
Director/Board Member 64 01/10/2010
Change 5-day change 1-year change 3-year change Capi.($)
-3.24%-2.02%+305.22%+953.18% 39Cr
+2.70%+2.73%+40.91%+110.31% 1,06000Cr
+1.44%-2.38%+36.83%+63.95% 62TCr
+1.75%+3.73%+16.55%+83.05% 48TCr
+0.60%-1.73%+62.98%+37.46% 35TCr
+2.92%+3.12%+24.78%+45.10% 35TCr
+2.42%+0.05%+14.13%+35.80% 27TCr
+1.86%-0.81%-4.69%+12.20% 25TCr
+2.60%-2.00%+39.77%+54.44% 22TCr
+1.82%-1.48%+25.75%+96.48% 18TCr
Average +0.99%-0.31%+56.22%+149.20% 37.88TCr
Weighted average by Cap. +0.81%+0.04%+32.03%+70.81%

Financials

2025 2026
Net sales 370.2Cr 3.83Cr 3.42Cr 3.19Cr 2.9Cr 5.46Cr 5.5Cr 38Cr 15Cr 188.27Cr 14Cr 14Cr 605.24Cr 503.08Cr 5.2Cr 4.65Cr 4.34Cr 3.94Cr 7.42Cr 7.47Cr 52Cr 20Cr 255.85Cr 20Cr 19Cr 822.5Cr
Net income 40Cr 41.19L 36.8L 34.34L 31.19L 58.74L 59.18L 4.13Cr 1.61Cr 20Cr 1.55Cr 1.51Cr 65Cr 67Cr 69.62L 62.2L 58.04L 52.71L 99.28L 1Cr 6.97Cr 2.72Cr 34Cr 2.61Cr 2.56Cr 110.11Cr
Net Debt 98Cr 1.01Cr 90.23L 84.18L 76.47L 1.44Cr 1.45Cr 10Cr 3.95Cr 50Cr 3.79Cr 3.71Cr 159.71Cr 127.11Cr 1.31Cr 1.17Cr 1.1Cr 99.5L 1.87Cr 1.89Cr 13Cr 5.14Cr 65Cr 4.93Cr 4.83Cr 207.82Cr
Projected Income Statement - Annual - Kwality Pharmaceuticals Limited
Logo Kwality Pharmaceuticals Limited
Kwality Pharmaceuticals Limited is an India-based company, which engages in the manufacturing & trading in pharmaceuticals & allied products. It engages in the business of manufacturers, buyers and sellers of and dealers in drugs intermediates, chemicals, extracts, alkaloids and other pharmaceutical goods, toilet requisites, medicines, beverages and other medical preparations. It also engages in research and development activities. It manufactures exports pharmaceutical formulations in liquid orals, powder for oral suspension, tablets, capsules, sterile powder for injections, small volume injectables, ointments, external preparations, oral rehydration solutions (ORS), and others in various categories like beta lactam and non-beta lactam, hormones, cytotoxic (oncology) and effervescent. The Company has approximately 48 different sections available at their production centers. Its subsidiary is Kwality Pharmaceuticals Africa Limitada.
Employees
1,137
Date Price Change Volume
08/26/08 ₹3,563.00 -3.24% 3,320
07/26/07 ₹3,682.25 -1.84% 4,457
06/26/06 ₹3,751.20 +3.01% 2,286
05/26/05 ₹3,641.50 +1.94% 5,448
01/26/01 ₹3,572.35 -1.76% 7,206

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Kwality Pharmaceuticals Limited